Virtus ETF Advisers’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,657
| Closed | -$85K | – | 467 |
|
|
2022
Q1 | $85K | Sell |
13,657
-814
| -6% | -$5.07K | 0.04% | 329 |
|
|
2021
Q4 | $183K | Buy |
14,471
+9,997
| +223% | +$126K | 0.07% | 241 |
|
|
2021
Q3 | $410K | Sell |
4,474
-229
| -5% | -$21K | 0.18% | 168 |
|
|
2021
Q2 | $249K | Sell |
4,703
-5,274
| -53% | -$279K | 0.1% | 213 |
|
|
2021
Q1 | $359K | Buy |
9,977
+173
| +2% | +$6.23K | 0.15% | 205 |
|
|
2020
Q4 | $272K | Buy |
9,804
+2,958
| +43% | +$82.1K | 0.11% | 269 |
|
|
2020
Q3 | $342K | Sell |
6,846
-938
| -12% | -$46.9K | 0.18% | 192 |
|
|
2020
Q2 | $360K | Sell |
7,784
-1,414
| -15% | -$65.4K | 0.17% | 252 |
|
|
2020
Q1 | $420K | Sell |
9,198
-1,355
| -13% | -$61.9K | 0.17% | 192 |
|
|
2019
Q4 | $592K | Buy |
+10,553
| New | +$592K | 0.1% | 191 |
|